Trial Profile
A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine TDS-Testosterone 5% in Adult Male Subjects
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Testosterone (Primary) ; Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics; Registrational
- Acronyms PARC-T-D
- Sponsors Transdermal Delivery Solutions Corp
- 30 Aug 2023 Planned End Date changed from 1 Feb 2024 to 1 Feb 2025.
- 30 Aug 2023 Planned primary completion date changed from 1 Oct 2023 to 1 Oct 2024.
- 30 Aug 2023 Planned initiation date changed from 1 Jun 2023 to 1 Jun 2024.